Выходит 4 номеров в год
ISSN Печать: 0731-8898
ISSN Онлайн: 2162-6537
Indexed in
c-Myc-Induced Genomic Instability
Краткое описание
c-myc is one of a small family of proto-oncogenes that do not require mutation to contribute to neoplastic transformation. Instead, the deregulated expression of the oncoprotein at even modest levels is sufficient to initiate this process. The transforming activity of c-Myc is generally thought to lie in its ability to modulate the expression of a series of genes, among them certain proliferation-promoting genes. In reality, c-Myc is a multifunctional protein that also affects the stability of the genome. In this review, we summarize the growing evidence that deregulated c-myc expression generates genomic instability by initiating gene amplification (both intra- and extra-chromosomally), gene rearrangements, and karyotypic instability. Cancer is a disease of impaired genomic stability, to which c-Myc contributes during its initiation and progression through the induction of genomic instability in critical genes. Myc thus acts as a structural modifier of the genome and as a promoter of neoplastic transformation.
-
Dominguez-Sola David, Ying Carol Y., Grandori Carla, Ruggiero Luca, Chen Brenden, Li Muyang, Galloway Denise A., Gu Wei, Gautier Jean, Dalla-Favera Riccardo, Non-transcriptional control of DNA replication by c-Myc, Nature, 448, 7152, 2007. Crossref
-
Kitange Gaspar, Misra Anjan, Law Mark, Passe Sandra, Kollmeyer Thomas M., Maurer Matthew, Ballman Karla, Feuerstein Burt G., Jenkins Robert B., Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas, Genes, Chromosomes and Cancer, 42, 1, 2005. Crossref
-
Boukamp Petra, Popp Susanne, Krunic Damir, Telomere-Dependent Chromosomal Instability, Journal of Investigative Dermatology Symposium Proceedings, 10, 2, 2005. Crossref
-
Guijon Fernando B., Greulich-Bode KM, Paraskevas Maria, Baker Patricia, Mai Sabine, Premalignant Cervical Lesions Are Characterized by Dihydrofolate Reductase Gene Amplification and c-Myc Overexpression, Journal of Lower Genital Tract Disease, 11, 4, 2007. Crossref
-
Patel Jagruti H., Loboda Andrey P., Showe Michael K., Showe Louise C., McMahon Steven B., Analysis of genomic targets reveals complex functions of MYC, Nature Reviews Cancer, 4, 7, 2004. Crossref
-
Krutmann Jean, Morita Akimichi, Mechanisms of Ultraviolet (UV) B and UVA Phototherapy, Journal of Investigative Dermatology Symposium Proceedings, 4, 1, 1999. Crossref
-
Wang Yi-Wei, Chang Hung-Shu, Lin Ching-Hui, Yu Winston C.Y., HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity, The International Journal of Biochemistry & Cell Biology, 39, 2, 2007. Crossref
-
Kuttler Fabien, Mai Sabine, Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis, Seminars in Cancer Biology, 17, 1, 2007. Crossref
-
Huang Sui, On the intrinsic inevitability of cancer: From foetal to fatal attraction, Seminars in Cancer Biology, 21, 3, 2011. Crossref
-
Liu Yu, Gong Li-Ping, Dong Xiao-Li, Liu Hong-Gang, Detection of C-MYC oncogene translocation and copy number change in the normal-dysplasia-carcinoma sequence of the larynx by fluorescence in situ hybridization, Diagnostic Cytopathology, 41, 6, 2013. Crossref
-
Wierstra Inken, Alves Jürgen, , 99, 2008. Crossref
-
Kildal Wanja, Risberg Björn, Abeler Vera M., Kristensen Gunnar B., Sudbø Jon, Nesland Jahn M., Danielsen Håvard E., β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: A study in 253 patients, European Journal of Cancer, 41, 8, 2005. Crossref
-
Beyer Valérie, Mühlematter Dominique, Parlier Valérie, Cabrol Christine, Bougeon-Mamin Sandrine, Solenthaler Max, Tobler Andreas, Pugin Paul, Gregor Michael, Hitz Felicitas, Hess Urs, Chapuis Bernard, Laurencet France, Schanz Urs, Schmidt Pierre-Michel, van Melle Guy, Jotterand Martine, Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases, Cancer Genetics and Cytogenetics, 160, 2, 2005. Crossref
-
Ponzielli Romina, Katz Sigal, Barsyte-Lovejoy Dalia, Penn Linda Z., Cancer therapeutics: Targeting the dark side of Myc, European Journal of Cancer, 41, 16, 2005. Crossref
-
Danescu Adrian, Herrero Gonzalez Sandra, Di Cristofano Antonio, Mai Sabine, Hombach-Klonisch Sabine, Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development, Genes, Chromosomes and Cancer, 52, 8, 2013. Crossref
-
Li Zhigang, Dong Lixue, Dean Eric, Yang Li, Acidosis Decreases c-Myc Oncogene Expression in Human Lymphoma Cells: A Role for the Proton-Sensing G Protein-Coupled Receptor TDAG8, International Journal of Molecular Sciences, 14, 10, 2013. Crossref
-
Guffei Amanda, Lichtensztejn Zelda, {ptdos} Santos Silva Amanda Gonçlves, Louis Sherif F., Caporali Andrea, Mai Sabine, c-Myc—Dependent Formation of Robertsonian Translocation Chromosomes in Mouse Cells, Neoplasia, 9, 7, 2007. Crossref
-
Deng Kaiyuan, Guo Xiaoqiang, Wang Hao, Xia Jiazeng, The lncRNA-MYC regulatory network in cancer, Tumor Biology, 35, 10, 2014. Crossref
-
Maire Georges, Yoshimoto Maisa, Chilton-MacNeill Susan, Thorner Paul S., Zielenska Maria, Squire Jeremy A., Recurrent RECQL4 Imbalance and Increased Gene Expression Levels Are Associated with Structural Chromosomal Instability in Sporadic Osteosarcoma, Neoplasia, 11, 3, 2009. Crossref
-
Bizari Lucimari, Silva Ana Elizabete, Tajara Eloiza H., Gene amplification in carcinogenesis, Genetics and Molecular Biology, 29, 1, 2006. Crossref
-
Boukamp Petra, Non-melanoma skin cancer: what drives tumor development and progression?, Carcinogenesis, 26, 10, 2005. Crossref
-
Kharazmi Jasmine, Moshfegh Cameron, Brody Thomas, Identification of cis-Regulatory Elements in the dmyc Gene of Drosophila Melanogaster, Gene Regulation and Systems Biology, 6, 2012. Crossref
-
Reed Steven I., The ubiquitin-proteasome pathway in cell cycle control, in Cell Cycle Regulation, 42, 2006. Crossref
-
Gong Lijie , Xia Yingjie , Qian Zhenyuan , Shi Ji , Luo Jungang , Song Guangyuan , Xu Ji , Ye Zaiyuan , Overexpression of MYC binding protein promotes invasion and migration in gastric cancer, Oncology Letters, 2018. Crossref
-
Park Sung Sup, Kim Joong Su, Tessarollo Lino, Owens James D., Peng Liangping, Han Seong Su, Tae Chung Seung, Torrey Ted A., Cheung Wan C., Polakiewicz Roberto D., McNeil Nicole, Ried Thomas, Mushinski J. Frederic, Morse Herbert C., Janz Siegfried, Insertion of c-Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice, Cancer Research, 65, 4, 2005. Crossref
-
Du Yan-ping, Peng Jun-sheng, Sun Ai, Tang Zhi-hong, Ling Wen-hua, Zhu Hui-lian, Assessment of the effect of betaine on p16 and c-mycDNA methylation and mRNA expression in a chemical induced rat liver cancer model, BMC Cancer, 9, 1, 2009. Crossref
-
Zeng Yijia, Wang Jin, Huang Qinwan, Ren Yuanyuan, Li Tingna, Zhang Xiaorui, Yao Renchuan, Sun Jilin, Cucurbitacin II a: A review of phytochemistry and pharmacology , Phytotherapy Research, 35, 8, 2021. Crossref
-
Fest Thierry, Guffei Amanda, Williams Gaynor, Silva Santiago, Mai Sabine, Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein, Oncogene, 24, 18, 2005. Crossref
-
Caporali A, Wark L, Vermolen B J, Garini Y, Mai S, Telomeric aggregates and end-to-end chromosomal fusions require myc box II, Oncogene, 26, 10, 2007. Crossref
-
Dai Mengyuan, Radhakrishnan Sridhar, Li Rui, Tan Ruirong, Yan Kuo, Fan Gang, Liu Miao, Targeted Protein Degradation: An Important Tool for Drug Discovery for “Undruggable” Tumor Transcription Factors, Technology in Cancer Research & Treatment, 21, 2022. Crossref
-
Felsher Dean W., Oncogene Addiction versus Oncogene Amnesia: Perhaps More than Just a Bad Habit?, Cancer Research, 68, 9, 2008. Crossref
-
Kim Suwon, Chin Koei, Gray Joe W., Bishop J. Michael, A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer , Proceedings of the National Academy of Sciences, 101, 46, 2004. Crossref
-
Yeh Elizabeth S., Lew Brian O., Means Anthony R., The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability, Journal of Biological Chemistry, 281, 1, 2006. Crossref
-
Arnes Jarle B., Brunet Jean-Sébastien, Stefansson Ingunn, Bégin Louis R., Wong Nora, Chappuis Pierre O., Akslen Lars A., Foulkes William D., Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer, Clinical Cancer Research, 11, 11, 2005. Crossref
-
Louis Sherif F., Vermolen Bart J., Garini Yuval, Young Ian T., Guffei Amanda, Lichtensztejn Zelda, Kuttler Fabien, Chuang Tony C. Y., Moshir Sharareh, Mougey Virginie, Chuang Alice Y. C., Kerr Paul Donald, Fest Thierry, Boukamp Petra, Mai Sabine, c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus, Proceedings of the National Academy of Sciences, 102, 27, 2005. Crossref
-
Cao Liangzi, Liu Xiaofang, Zheng Bowen, Xing Chengzhong, Liu Jingwei, Role of K63-linked ubiquitination in cancer, Cell Death Discovery, 8, 1, 2022. Crossref
-
Li Chun, Zhou Zunzhen, Ren Chao, Deng Yi, Peng Feng, Wang Qiongfen, Zhang Hong, Jiang Yuan, Triplex-forming oligonucleotides as an anti-gene technique for cancer therapy, Frontiers in Pharmacology, 13, 2022. Crossref
-
GEETIKA GEETIKA, SODHI S S, MUKHOPADHYAY C S, RAMNEEK RAMNEEK, SETHI R S, Pulmonary expression of MYCN mRNA following exposure to 2,4-D with or without endotoxin challenge, The Indian Journal of Animal Sciences, 89, 11, 2019. Crossref